3F #7_Attach2F_Advocates

Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery

#7_OSPO_Attach 2F_Advocates (Section F)

Bundled Sub-studies #5 DCP Survey, #6 R2R Survey, and #7 PS-OC Survey

OMB: 0925-0642

Document [pdf]
Download: pdf | pdf
PS-OC Survey: Advocates (Section F)
OMB No.: 0925-0642
Expiration Date: 9/30/2014
Notification to Respondent of Estimated Burden
Public reporting burden for this collection of information is estimated to average 15
minutes per response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed, and completing
and reviewing the collection of information.  An agency may not conduct or
sponsor, and a person is not required to respond to, a collection of information
unless it displays a currently valid OMB control number.  Send comments
regarding this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to: NIH, Project Clearance Branch,
6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA
(0925-0642).  Do not return the completed form to this address.
1. Please identify your primary affiliation with the Physical Sciences - Oncology Centers Program.
Please pick one of the answers below.

Center Principal Investigator (PI)
Center Senior Scientific Investigator (SI)
PS-OC Project/Core Investigators (i.e. project/core leader or research investigator)
PS-OC Trainee
PS-OC Advocate
PS-OC Outreach and Dissemination Unit Lead
PS-OC Education and Training Unit Lead
PS-OC Administrator
PS-OC External Advisor
I am not associated with the PS-OC Program

Section F. The following section contains questions specific for PS-OC program
advocates.

Page 1 of

5

2. F1. What is your role as an advocate in the PS-OC prorgam?  Please check all that apply.
Please check all that apply and/or add your own variant.

Participate in the annual meeting
Site visits
Scienctific discussions
Provide guidance and answer questions
Review proposals
Attend workshops
Write publications (scholarly or lay)
Present to the public
Other
.................................................. .................................................. .................................................. .....................................

3. F2. How often do you meet with the following groups?
Please mark the corresponding circle - only one per line.

Never

Yearly

Monthly

Weekly

Daily

Other PS-OC Advocates
The PS-OC Network
Advocate
The Principal Investigator of
the PS-OC
The entire PS-OC in which
you participate

4. F3. Are you involved in any other NCI programs? If yes, please list in the comment box.
Please pick one of the answers below and add your comments.

Yes
No
Other or Unsure

.................................................. .................................................. .................................................. .....................................

Page 2 of

5

5. F4. How do you feel the PS-OC Network compares to the other programs?
Please mark the corresponding circle - only one per line.

Inferior

Neutral

Superior

6. F5. Please describe any suggestions you have for improving advocate involvement in the PS-OC
Program
Please write your answer in the space below.

.................................................. .................................................. .................................................. .....................................

.................................................. .................................................. .................................................. .....................................

.................................................. .................................................. .................................................. .....................................

.................................................. .................................................. .................................................. .....................................

The following question inquires about your views on the progress the PS-OC
program is making relative to the goals of the program.

Page 3 of

5

7. From your standpoint, please evaluate the extent to which the PS-OC program has been
successful in reaching the following program goals.
Please mark the corresponding circle - only one per line.

I do not
know

Very Poor

Poor

Fair

Good

Excellent

Form trans-disciplinary
teams focused on
establishing physical
sciences-centric themes in
cancer research
Build a collaborative transdiscipline research sharing
network
Promote collaboration by
PS-OC researchers across
the PS-OC network
Educate trans-disciplinary
scientists that pursue
careers in the field of
physical sciences in
oncology
Promote collaboration by
PS-OC researchers beyond
the PS-OC network
Form new physical sciences
in oncology programs at
universities or institutions
Test dogma-challenging
hypothesis on cancer
initiation and progression
Bring new types of
scientists to cancer
research
Generate new datasets in
cancer research
Generate new knowledge in
cancer research

Page 4 of

5

8. Please provide any additional comments that you would like to share about the convergence of
physical sciences in oncology or the PS-OC program.
Please write your answer in the space below.

.................................................. .................................................. .................................................. .....................................

.................................................. .................................................. .................................................. .....................................

.................................................. .................................................. .................................................. .....................................

.................................................. .................................................. .................................................. .....................................

Page 5 of

5


File Typeapplication/pdf
File Modified2012-02-24
File Created2012-02-24

© 2024 OMB.report | Privacy Policy